Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
13.25
-0.66 (-4.74%)
At close: Sep 8, 2026, 4:00 PM EDT
13.30
-0.61 (-4.39%)
Pre-market: Sep 9, 2026, 8:01 AM EDT
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $947.9 million as of September 8, 2026. Its market cap has increased by 1,429.03% in one year.
Market Cap
947.90M
Enterprise Value
716.79M
1-Year Change
1,429.03%
Ranking
Category
Stock Price
$13.25
ChartMarket Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $947.90M, an increase of 1,341.81%. That is a compound annual growth rate of 75.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 8, 2026 | 947.90M | 243.94% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lexicon Pharmaceuticals | 992.25M |
| SpyGlass Pharma | 984.21M |
| Geron | 970.13M |
| Candel Therapeutics | 965.66M |
| Olema Pharmaceuticals | 960.72M |
| Wave Life Sciences | 955.68M |
| Design Therapeutics | 941.85M |
| Ardelyx | 939.44M |